Reports

7777 Results (Page 1 of 312)

All Market Research Reports

Pharmaceuticals

South Africa Dermatological Therapeutics Market Analysis

South Africa Dermatological Therapeutics Market is at around $0.27 Bn in 2022 and is projected to reach $0.52 Bn in 2030, exhibiting a CAGR of 9.83% during the forecast period. The market is expanding due to a rise in the elderly population, increased awareness and education, and a surge in dermatological conditions. The market is dominated by key players like Aspen Pharmacare, Adcock Ingram, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Dermatological Therapeutics Market Analysis

Kenya Dermatological Therapeutics Market is at around $0.03 Bn in 2023 and is projected to reach $0.06 Bn in 2030, exhibiting a CAGR of 9.7% during the forecast period. The expansion of the market is driven by factors such as government initiatives, healthcare infrastructure development, changing lifestyles, and environmental factors. The market is dominated by key players like Glenmark Pharmaceuticals, Universal Pharmaceuticals Limited, Cosmos Limited, Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Dermatological Therapeutics Market Analysis

Egypt Dermatological Therapeutics Market is at around $0.12 Bn in 2023 and is projected to reach $0.23 Bn in 2030, exhibiting a CAGR of 10.10% during the forecast period. The factors driving the expansion of the market are rising awareness, the prevalence of skin disorders, and advancements in treatment technologies. The market is dominated by key players like Egyptian International Pharmaceutical Co. (EPICO), Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Dermatological Therapeutics Market Analysis

Vietnam Dermatological Therapeutics Market is at around $0.21 Bn in 2023 and is projected to reach $0.37 Bn in 2030, exhibiting a CAGR of 8.83% during the forecast period. Advances in technology, the prevalence of skin disorders, and increased awareness of skin health are driving the expansion of the market. The market is dominated by key players like Almirall SA, Pfizer Inc., GlaxoSmithKline Plc (GSK), AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Singapore Dermatological Therapeutics Market Analysis

Singapore Dermatological Therapeutics Market is at around $0.05 Bn in 2023 and is projected to reach $0.09 Bn in 2030, exhibiting a CAGR of 9.2% during the forecast period. The market is expanding as a result of the prevalence of skin conditions, rising awareness, and consumer preferences for aesthetic procedures. The market is dominated by key players like Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Dermatological Therapeutics Market Analysis

Philippines Dermatological Therapeutics Market is at around $0.09 Bn in 2023 and is projected to reach $0.17 Bn in 2030, exhibiting a CAGR of 9.1% during the forecast period. The market is expanding due to factors such as the aging population, changing lifestyles, and an increase in dermatological conditions. The market is dominated by key players like Unilab, Mercury Drug Corporation, Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Dermatological Therapeutics Market Analysis

Malaysia Dermatological Therapeutics Market is at around $0.07 Bn in 2023 and is projected to reach $0.12 Bn in 2030, exhibiting a CAGR of 8.8% during the forecast period. The market is being driven by rising healthcare awareness, an increase in dermatological conditions, and technological advancements. The market is dominated by key players like Pharmaniaga Berhad, Duopharma Biotech Berhad, Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Japan Dermatological Therapeutics Market Analysis

Japan Dermatological Therapeutics Market is at around $2.56 Bn in 2023 and is projected to reach $4.71 Bn in 2030, exhibiting a CAGR of 9.1% during the forecast period. The market is being driven by an increasing aging population, a growing prevalence of dermatological disorders, and technological advancements in treatment options. The market is dominated by key players like Takeda Pharmaceutical Company Limited (JPN), Shionogi & Co., Ltd. (JPN), Eisai Co., ltd. (JPN), Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, Johnson & Johnson, and GlaxoSmithKline Plc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Dermatological Therapeutics Market Analysis

Indonesia Dermatological Therapeutics Market is at around $0.25 Bn in 2023 and is projected to reach $0.44 Bn in 2030, exhibiting a CAGR of 8.6% during the forecast period. The market is expanding due to an increase in dermatological disorders, increased awareness about skin diseases, and technological advancements. The market is dominated by key players like PT Kalbe Farma Tbk (IDN), PT Kimia Farma Tbk (IDN), PT Sanbe Farma (IDN), Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, Johnson & Johnson, and GlaxoSmithKline Plc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Dermatological Therapeutics Market Analysis

China Dermatological Therapeutics Market is at around $3.34 Bn in 2023 and is projected to reach $6.54 Bn in 2030, exhibiting a CAGR of 10.1% during the forecast period. The market is growing as a result of urbanization, increasing elderly population, and growing awareness. The market is dominated by key players like Fosun Pharma (CHN), Sinopharm (CHN), Jiangsu Hengrui Medicine (CHN), CSPC Pharmaceutical Group (CHN), Hualan Biological Engineering (CHN), Harbin Pharmaceutical Group (CHN), Yunna Baiyao Group (CHN), Sino Biopharmaceutical (CHN), Pfizer, Johnson & Johnson, Novartis AG, and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UK Dermatological Therapeutics Market Analysis

UK Dermatological Therapeutics Market is at around $1.04 Bn in 2023 and is projected to reach $1.63 Bn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The market is driven by the rising prevalence of skin disorders, developments in dermatology research and technology, and patient awareness and education. The market is dominated by key players like LEO Pharma, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, Gladerma Laboratories, Johnson & Johnson, Eli Lilly and Company, and GlaxoSmithKline Plc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Spain Dermatological Therapeutics Market Analysis

Spain Dermatological Therapeutics Market is at around $0.78 Bn in 2023 and is projected to reach $1.31 Bn in 2030, exhibiting a CAGR of 7.6% during the forecast period. The market is expanding due to factors such as trends in cosmetic dermatology, healthcare infrastructure and access to dermatological care, and advancements in dermatology technology. The market is dominated by key players like Skin Tech Pharma, Grupo Juste, Merck KGaA, Boehringer Ingelheim, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, and Gladerma Laboratories.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Germany Dermatological Therapeutics Market Analysis

Germany Dermatological Therapeutics Market is at around $1.47 Bn in 2023 and is projected to reach $2.34 Bn in 2030, exhibiting a CAGR of 6.8% during the forecast period. The market is being driven by an aging population, an increase in dermatological conditions, and advances in research and development. The market is dominated by key players like Beiersdorf, Stada Arzneimittel, Merck KGaA, Boehringer Ingelheim, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, and Gladerma Laboratories.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

France Dermatological Therapeutics Market Analysis

France Dermatological Therapeutics Market is at around $1.12 Bn in 2022 and is projected to reach $1.86 Bn in 2030, exhibiting a CAGR of 7.6% during the forecast period. The market is propelling due to the rising incidence of dermatological conditions, increasing awareness about skin disorders, and growing demand for cosmetic dermatology. The market is dominated by key players like Pierre Fabre (France), Boiron (France), Lallemand Pharma (France), Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, Gladerma Laboratories, and Bausch Health Companies Inc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Dermatological Therapeutics Market Analysis

Mexico Dermatological Therapeutics Market is at around $0.62 Bn in 2022 and is projected to reach $1.11 Bn in 2030, exhibiting a CAGR of 8.85% during the forecast period. The market is rapidly expanding as a result of the increased prevalence of dermatological conditions, rising awareness about skin disorders, and technological advancements in the industry. The market is dominated by key players like Genomma Lab Internacional, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma Laboratories, Bausch Health Companies Inc., Novartis AG, Eli Lily and Company, and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Dermatological Therapeutics Market Analysis

Brazil Dermatological Therapeutics Market is at around $1.03 Bn in 2023 and is projected to reach $1.96 Bn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The market is growing due to factors such as rising dermatological disorders, e-commerce and digital marketing, and technological advancements. The market is dominated by key players like Hypermarcas, Ache Laboratorios Farmaceuticos S.A., EMS: Industria Farmaceutica S.A., Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UAE Dermatological Therapeutics Market Analysis

UAE Dermatological Therapeutics Market is at around $0.21 Bn in 2023 and is projected to reach $0.39 Bn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The market is being driven by advancements in dermatological research, medical tourism, and growing awareness of skin health. The market is dominated by key players like Neopharma, Julphur, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Dermatological Therapeutics Market Analysis

Saudi Arabia Dermatological Therapeutics Market is at around $0.71 Bn in 2023 and is projected to reach $1.38 Bn in 2030, exhibiting a CAGR of 10.1% during the forecast period. The market is expanding due to trends in cosmetic dermatology, supportive regulatory frameworks, and growing distribution networks. The market is dominated by key players like Jamjoom Pharma Company, Tabuk Pharmaceutical Manufacturing Company, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Dermatological Therapeutics Market Analysis

Canada Dermatological Therapeutics Market is at around $3.28 Bn in 2023 and is projected to reach $5.84 Bn in 2030, exhibiting a CAGR of 8.6% during the forecast period. The market is growing due to factors such as the rising prevalence of skin disorders, the aging population, and technological developments. The market is dominated by key players like Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Dermatological Therapeutics Market Analysis

US Dermatological Therapeutics Market is at around $16.88 Bn in 2023 and is projected to reach $26.40 Bn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The development of innovative therapies, the growing trend of cosmetic dermatology, and the increasing prevalence of skin conditions are driving the growth of the market. The market is dominated by key players like Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Healthcare Services

Ukraine Dental Care Market Analysis

This report presents a strategic analysis of the Ukraine Dental Care Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Ukraine Dental Care Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Vitamin and Minerals Market Analysis

This report presents a strategic analysis of the US Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the US Vitamin and Minerals Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Digital Health

US Telemedicine Market Analysis

US telemedicine market size is at around $25.54 Bn in 2022 and is projected to reach $84.88 Bn in 2030, exhibiting a CAGR of 16.2% during the forecast period. With 67 Mn people in the US reporting having active wearable devices with 82.38% willing to share the data collected with their healthcare providers telemedicine is an untapped and potentially sizeable market. Major players like MDlive, Amwell, Teladoc Health, and Doctor on Demand are yet to scale up to their maximum operations.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Healthcare Services

US Robotic Surgery Services Market Analysis

US's Robotic Surgery Service market size was valued at $1.80 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.3% % from 2022-30 and will reach $6.4Bn in 2030. The robotic surgery service market will grow due to robotic surgery technology having made complex surgical procedures more accessible, especially in rural areas where access to specialized surgeons may be limited. The market is segmented by product and service type, application type, and end user. Some of the major players are Intuitive Surgical (USA), Stryker Corporation (USA), Mazor Robotics (USA), Medtronic (USA), and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Clinical Trials

US Oncology Clinical Trials Market Analysis

This report presents a strategic analysis of the US Oncology Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the US Oncology Clinical Trials Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up